COMMUNIQUÉS West-GlobeNewswire

Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
11/06/2026
– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial – – 96% CRc in newly diagnosed NPM1-m AML; 90% CRc in newly diagnosed KMT2A-r AML – – High rates of MRD [...]
Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients
11/06/2026
Media Release COPENHAGEN, Denmark; June 11, 2026 Findings from a post-hoc subgroup analysis of the Phase 3 EPCORE ® FL-1 trial reinforce fixed-duration epcoritamab in combination with rituximab and lenalidomide (R 2 ) [...]
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
11/06/2026
IRVINE, Calif., June 11, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointment of Cris Calsada as Chief Financial Officer (CFO) and Claire Padgett, Ph.D., as Senior Vice President (SVP) of [...]
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11/06/2026
- Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining seven patients in the [...]
Arizona Nonprofit Launches “America 250” Fundraiser Featuring 250 Winners to Support Childhood Blindness Research
11/06/2026
A Race Against Blindness celebrates America’s 250th anniversary with a major fundraising campaign featuring vehicles, cash prizes, and a life-changing impact for children facing blindness GILBERT, Ariz., June 11, 2026 ( [...]
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
11/06/2026
PMA supplement under FDA review with potential approval in H2 2026, potentially expanding the Company’s addressable market to include TCAR in addition to CAS carotid stenting procedures MIAMI, June 11, 2026 (GLOBE [...]
Imviva Biotech Presents Studies on CTD402 Allogeneic CAR-T Therapy at EHA2026 Congress
11/06/2026
Pooled Phase 1/2 data show 80% complete remission rate in pediatric R/R T-ALL/LBL patients Global TENACITY-01 study reports 86% overall response rate in adults with R/R T-ALL/LBL BOSTON, June 11, 2026 (GLOBE NEWSWIRE [...]
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
11/06/2026
BOSTON, June 11, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply [...]
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
11/06/2026
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demonstrate a favorable [...]
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
11/06/2026
Management Believes the Company is Entering a Transformative Stage with a Novel, First-In-Class Cancer Therapy for Treatment & Prevention of Metastatic Cancer from Solid Tumors MELBOURNE, Australia, June 11, 2026 ( [...]
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
11/06/2026
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its participation at HLTH [...]
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
11/06/2026
The clearance combines OraSure’s Colli-Pee™•Dx Urine Collection Kit for at-home sample collection with Roche’s cobas® molecular lab testing equipment BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure [...]
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
11/06/2026
Company earns five Golds for its interactive patient education tools, health literacy content, and evidence-based behavioral health apps ATLANTA, June 11, 2026 (GLOBE NEWSWIRE) -- Sharecare, the digital health [...]
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026
Presentations, panels and moderated discussions across the four-day conference will span proven AI applications across the clinical trial lifecycle, real world evidence, risk-based quality management and patient- [...]
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
11/06/2026
Structured Market Entry Includes Initial Purchase Order and Pathway to Five-Year Commercial Partnership VANCOUVER, BC, June 11, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a [...]
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM
11/06/2026
Flyte to expand private aviation demand, increase aircraft utilization, and accelerate revenue growth Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities [...]
Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
11/06/2026
BERWYN, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- Titan CEO and headline sponsor Cherry Bekaert are pleased to announce Dea Belazi, CEO and co-founder, AscellaHealth , a global partner delivering customizable solutions for [...]
Pharvaris Announces Annual General Meeting of Shareholders
11/06/2026
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]

Pages